Switch to:
More From Other Websites
ETFs with exposure to Biogen, Inc. : April 28, 2017 Apr 28 2017
What's Worrying Me About Biogen Apr 28 2017
Biogen Has Developed a Robust Access Strategy for Spinraza Apr 28 2017
Biogen’s Spinraza Witnessed Robust Patient Demand in 1Q17 Apr 28 2017
These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016 Apr 28 2017
How Biogen’s Tysabri and Zinbryta Performed in 1Q17 Apr 28 2017
Mixed bag for biotech earnings Apr 27 2017
Biogen, Inc. :BIIB-US: Earnings Analysis: Q1, 2017 By the Numbers : April 27, 2017 Apr 27 2017
Biogen Still Dominated the Multiple Sclerosis Market in 1Q17 Apr 27 2017
Analysts’ Recommendations for Biogen in 1Q17 Apr 27 2017
Biogen Reports Strong Revenue Growth in 1Q17 Apr 27 2017
Edited Transcript of BIIB earnings conference call or presentation 25-Apr-17 12:30pm GMT Apr 26 2017
Biogen Inc. Earnings: New Drug Sparks Life Apr 26 2017
​Hyde Park boy with rare disease wins appeal, will receive Biogen drug Apr 26 2017
Stock Market News for April 26, 2017 Apr 26 2017
Biogen, Inc. breached its 50 day moving average in a Bullish Manner : BIIB-US : April 26, 2017 Apr 26 2017
Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug Apr 26 2017
Today's Research Reports on Stocks to Watch: Lockheed Martin and Biogen Apr 26 2017
Better Buy: Amgen Inc. vs. Biogen Apr 26 2017
Spinraza's Fast Start Puts Ionis on a Path to Profit Apr 25 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK